About us
A innovative Peptide CDMO service provider
• What we do
Yifan Biopharma is a innovative Peptide CDMO service provider. With 10+ years of expertise in peptide synthesis and API development, Yifan Biopharma has proudly completed over 200 successful CDMO projects. We deliver comprehensive, end-to-end solutions—from custom peptide synthesis strategy, API process development, sterile injectable formulation, and cGMP-compliant analytical testing service.
Using world-class quality systems, flexible manufacturing capabilities, and unwavering regulatory excellence, Yifan Biopharma shorten your project timelines, ensures product quality and compliance, and help clients rapidly advance from clinical development to commercial launch—successfully reaching global markets such as U.S. and Europe.
Partner with Yifan Biopharma—where quality meets speed, and innovation drives results.
• Vision and strategy
Yifan Biopharma is guided by an experienced executive team that supports sustainable growth, operational reliability, and long-term partnerships. Our vision is to enable the next generation of tides therapies worldwide. Our strategy focuses on disciplined investment in technology, capacity, and global operations to ensure long-term value creation for partners.
Our mission is to address unmet medical needs by leveraging high-throughput screening and chemical optimization to develop peptide drugs across various therapeutic areas.
Company Outline
130+ Employees
More than 60% of the R&D team members have master’s or doctoral degrees, and the core team members have accumulated more than 20 years of research and development experience in the field of peptides.
1 Intelligent drug manufacturing base
More than 12000 m2 of intelligent manufacturing base, which meet the GMP conditions for drug production.
2 Research and pilot centers
CN+USA RD centers, which can meet the needs of different customers and product development requirements.
Metric tons-level production capacity
Efficient GMP large‑scale production to support your path from discovery to commercial supply.